Merck & Co., Inc. (NEO:MRK)

Market Cap	298.74B
Revenue (ttm)	86.76B
Net Income (ttm)	22.38B
Shares Out	n/a
EPS (ttm)	8.84
PE Ratio	13.35
Forward PE	9.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,160
Average Volume	11,160
Open	19.46
Previous Close	19.38
Day's Range	19.30 - 19.46
52-Week Range	16.84 - 22.39
Beta	n/a
RSI	63.06
Earnings Date	Jul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1891
• Employees: 75,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: MRK

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD